Minimally invasive surgical instruments market seen reaching $70.9B by 2030

The global market for minimally invasive surgical instruments is projected to grow from $42.87 billion in 2025 to $47.55 billion in 2026, with North America holding the largest share and Asia-Pacific emerging as the fastest-growing region. The expansion reflects rising surgical volumes, greater use of robot-assisted procedures and broader adoption of less invasive techniques across medical specialties.

Why it matters: - Minimally invasive surgical instruments are gaining share because hospitals and surgeons want smaller incisions, less tissue damage and faster recovery times. - The market’s growth tracks with rising surgical volumes worldwide, which increases demand for tools that improve precision and shorten recovery. - The shift also reflects wider adoption of robot-assisted surgery, advanced imaging-compatible devices and single-use instruments.

What happened: - The minimally invasive surgical instruments market is projected to rise from $42.87 billion in 2025 to $47.55 billion in 2026. - The market is forecast to reach $70.89 billion by 2030. - The 2026 forecast implies a 10.9% CAGR from 2025 to 2026. - The longer-term outlook points to a 10.5% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing regional market.

The details: - The category includes laparoscopes, endoscopes and specialized graspers used to operate through small incisions. - These instruments support greater visualization and control in complex anatomical areas. - The tools are designed to reduce patient trauma and speed recovery. - Growth in the market has been driven by more minimally invasive procedures, stronger patient and provider preference for shorter hospital stays, wider use of laparoscopic surgery, specialized instrument availability and surgeon training programs. - Future growth is expected to be supported by robot-assisted surgeries, investment in surgical technology, growth in ambulatory surgical centers, stronger focus on patient safety and broader use across medical specialties. - The report highlights rising demand for precision-control instruments, improved ergonomic designs, advanced imaging-compatible devices and single-use products. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - A free sample is available through the market report sample. - The full report is available through the company’s market report page.

Between the lines: - The report points to a market moving from broad adoption to feature-level differentiation, with robotics, imaging compatibility and ergonomics shaping product demand. - North America’s lead suggests mature adoption, while Asia-Pacific’s growth outlook signals where much of the next-wave expansion is likely to occur. - The increase in elective surgeries in Australia underscores how higher procedure volumes can translate into sustained instrument demand. - The Australian Institute of Health and Welfare reported 778,500 patients were admitted for surgery from public hospital elective surgery waiting lists in 2023-24, up 5.8% from the previous year.

What's next: - The market is expected to keep expanding as hospitals adopt more minimally invasive and robot-assisted procedures. - More growth is likely to come from ambulatory surgical centers and specialty-specific use cases. - Product development is likely to stay centered on precision, safety, single-use formats and ergonomic design.

The bottom line: - Minimally invasive surgical instruments are moving from a growth category to a core part of modern surgery, with demand reinforced by higher procedure volumes and steady technology upgrades.